Answers are grounded in this paper and cite their sources.
The unprecedented volume and speed at which COVID-19-related systematic reviews (SRs) may have been produced has raised questions regarding the quality of this evidence. It is feasible that pandemic-related factors may have led to an impairment in quality (reduced internal validity, increased risk of bias [RoB]). This may have serious implications for decision-making related to public health and individual healthcare.
No takes yet. Share an insight, caveat, or question.
McDermott et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: